Provided by Tiger Fintech (Singapore) Pte. Ltd.

MannKind

4.58
+0.14003.15%
Post-market: 4.690.1100+2.40%19:42 EDT
Volume:1.73M
Turnover:7.93M
Market Cap:1.39B
PE:45.80
High:4.69
Open:4.49
Low:4.48
Close:4.44
Loading ...

MannKind's (NASDAQ:MNKD) investors will be pleased with their incredible 393% return over the last five years

Simply Wall St.
·
12 Dec 2024

BUZZ-MannKind rises after India approves insulin inhalation powder

Reuters
·
11 Dec 2024

MannKind, Cipla Say Afrezza Inhalation Powder Approved for Diabetes in India

MT Newswires Live
·
11 Dec 2024

MannKind Corp: Expects to Ship Product for Cipla Ltd. by End of 2025

THOMSON REUTERS
·
11 Dec 2024

MannKind Corp: Central Drugs Standard Control Organisation (Cdsco) in India Has Approved Afrezza Inhalation Powder in Adults

THOMSON REUTERS
·
11 Dec 2024

Optimistic Buy Rating for MannKind’s MNKD-201 Program Bolstered by Inhaled Drug Development Success

TIPRANKS
·
25 Nov 2024

Tudor Pickering Holt Downgrades MannKind to Hold From Buy, Adjusts Price Target to $5.50 From $7

MT Newswires Live
·
15 Nov 2024

MannKind’s Growth Momentum and Increased Confidence in Pipeline Elevate Buy Rating

TIPRANKS
·
11 Nov 2024

MannKind Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
09 Nov 2024

MannKind price target raised to $7 from $5 at RBC Capital

TIPRANKS
·
09 Nov 2024

RBC Capital Adjusts Price Target on MannKind to $7 From $5, Maintains Sector Perform Rating

MT Newswires Live
·
08 Nov 2024

Stock Track | MannKind Shares Plunge Despite Q3 Beat as Afrezza Concerns Linger

Stock Track
·
08 Nov 2024

Stock Track | MannKind Shares Plunge 5% Pre-Market Despite Q3 Beat on Afrezza Concerns

Stock Track
·
08 Nov 2024

MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com
·
08 Nov 2024

MannKind Corp : RBC Raises Target Price to $7 From $5

THOMSON REUTERS
·
08 Nov 2024

MannKind Corp reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
08 Nov 2024

MannKind Corporation Reports Strong Quarterly Growth

TIPRANKS
·
08 Nov 2024

MannKind (MNKD) Q3 2024 Earnings Call Transcript

Motley Fool Transcribing
·
08 Nov 2024

MannKind Q3 2024 Adj. EPS $0.06 Beats $0.03 Estimate, Sales $70.079M Miss $74.500M Estimate

Benzinga
·
08 Nov 2024

MannKind Corp : Qtrly Shr $ 0.04

THOMSON REUTERS
·
08 Nov 2024